|  | Cancer | Skin Cancer

Moderate Dysplastic Nevi: Management Guidelines and Removal Criteria

Moderate dysplastic nevi (MDN) are melanocytic lesions with architectural/cytologic atypia between mild and severe. Management is individualized.

Risk Stratification Factors

  • Histopathology: Grading (mild/moderate/severe) — moderate shows bridging nests, lamellar fibroplasia, moderate cytologic atypia.
  • Clinical/Dermoscopic: Asymmetry, irregular borders, color variegation, >5mm, atypical network/globules.
  • Count: >5–10 MDN = "dysplastic nevus syndrome" → ↑ melanoma risk (6–10% lifetime).
  • Personal/Family History: Prior melanoma or ≥1 FDR with melanoma → lower threshold for excision.
  • Age: Younger patients — longer surveillance horizon; consider excision for high-risk features.

Management Options

Consensus Statements

  • NIH/ACR: Excision for moderate/severe dysplasia with positive margins; observation acceptable for moderately dysplastic with clear margins.
  • NCCN: Individualize; no universal excision mandate.

Patient-Centered Decision

Shared decision-making: Review risk data, cosmetic/functional impact of excision, surveillance burden, patient values.

Skin Cancer - Related Articles

Health Sciences © https://www.222health.com

ApproachIndication
Observation (q6–12m dermoscopy)Single/small MDN, low-risk features, reliable follow-up
Excision (narrow margin 2–3mm)High-risk features, patient anxiety, unreliable follow-up, >10 MDN with worst lesion
Photographic surveillanceMultiple MDN; baseline total body photography + dermoscopy